Bloodstream infection (BSI) is a frequent and life-threatening complication in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-SCT) and rapid identification of pathogens is critical. 1, 2 Pre-engraftment BSI is also a risk factor for acute GvHD, 3 delayed neutrophil recovery, 4 and non-relapsemortality 5, 6 after allo-SCT. Rapid identification of the causative bacteria in BSI is critical in order to improve the transplant outcome.
Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been widely used for the identification of bacterial and fungal species in culture specimens. It identifies bacterial genus and species by profiling of bacterial ribosomal proteins. 7, 8 However, usefulness of MALDI-TOF MS in BSI during allo-SCT remains to be investigated.
We retrospectively analyzed the cases of 80 patients who underwent allo-SCT in Hokkaido University Hospital between January 2014 and December 2015. Data of patient's characteristics, transplant procedures and infectious complications were retrospectively collected. The institutional review board approved the study protocols and written informed consent was obtained from all patients in accordance with the Declaration of Helsinki. Disease status was defined, as described previously. 9 Myeloablative conditioning regimens were combination of total body irradiation (TBI, 12 Gy) and cyclophosphamide (CY), or fludarabine and busulfan (14.4 mg/kg). Reduced-intensity conditioning regimens were fludarabine in combination with either busulfan (7.2 mg/kg) 10 or melphalan (80 or 140 mg/m 2 ), with or without 2-4 Gy TBI. Levofloxacin, micafungin, acyclovir, and sulfamethoxazole/trimethoprim or atovaquone were administered for prophylaxis against bacterial, fungal, viral and Pneumocystis jiroveci infections, respectively. BSI was defined as described previously. 11 Briefly, two sets of blood culture specimens were obtained, one from a peripheral vein and the other from the central catheter, when a febrile episode (axillary temperature ⩾ 38°C) occurred. BSI was defined as the isolation of bacteria from at least 1 blood culture except for common skin contaminants such as Corynebacterium species and coagulase-negative staphylococci that require detection from 2 separate samples. Blood culture was performed in BACTEC PLUS bottles (Becton Dickinson, Franklin Lakes, NJ, USA) with a BACTEC FX system (Becton Dickinson Microbiology Systems, Franklin Lakes, NJ, USA) for up to 72 h. Positive blood culture specimens were directly subjected to MALDI-TOF MS using a MALDI Sepsityper Kit (Bruker Daltonics, Bremen, Germany) without culture with solid media. The bacterial genus or species in the solution were identified using a MALDI Biotyper 3.1 (Bruker Daltonics). This system is fully automated and it does not require manual interpretation of data by an operator. The MALDI Biotyper measures highly abundant proteins that are found in all microorganisms and identifies particular microorganisms by matching protein relative abundance pattern of the samples to those within database. Positive blood culture is also applied for gram staining and bacterial subculture on agar plates for a few days, followed by colorimetric and fluorescence identification using a Micro Scan Walk Away 96 Plus system (Siemens Healthcare Diagnostics, Erlangen, Germany). Test sensitivity was assessed by concordance rates of the results from MALDI-TOF MS and the conventional test. To calculate the sensitivity and specificity of MALDI-TOF MS, we performed cross tabulation analyses, in which conventional identification was set as the gold standard.
To compare the specificity, we used a Fisher's exact test. P o 0.05 was considered to be as statistically significant. All statistical analyses were performed using Graph Pad Prism 5 software (GraphPad Software, CA, USA). Eighty patients underwent SCT during the study period. Table 1 displays characteristics of 43 patients who had episodes of BSI. The incidences of grade II-IV and grade III-IV acute GvHD were 18.6% and 7.0%, respectively. Two patients (4.7%) died from bacterial (Stenotrophomonas maltophilia) or fungal infection, whereas no patient died from the underlying disease. Table 2 also showed etiologies of 92 episodes of BSI identified by the conventional method. In 51 (55.4%) of the 92 episodes, gram-positive cocci (GPC) were detected. The predominant species was Staphylococcus epidermidis, accounting for 68.6% of GPC. All of the Staphylococcus epidermidis were methicillin resistant. Gram-positive rods were identified in 14 episodes (15.2%), with 13 episodes by Corynebacterium species. In 24 (26.0%) of 92 positive blood cultures, Gram-negative rods (GNR) were detected with 41.7% of Stenotrophomonas maltophilia, 34.6% of Pseudomonas species and 4.2% of extended spectrum beta lactamase (ESBL) Escherichia coli.
MALDI-TOF MS identified the causative bacteria in 73 of 92 episodes of BSI; the overall sensitivity was 79.3% (Table 2) . Causative bacteria identified by MALDI-TOF MS were exclusively consistent with those identified by the conventional method. Remarkably, MALDI-TOF MS identified the bacteria at the species level in all detectable episodes (73/73), whereas the conventional method identified the species level in 74/92 (80.4%). The sensitivity of MALDI-TOF MS for GPC and GNR was similar; 86.3% and 83.3%, respectively. MALDI-TOF MS significantly reduced time to identify bacteria, it took 0.91 ± 0.57 days from the blood sampling with MALDI-TOF MS, whereas the conventional method took 3.63 ± 0.85 days from the blood sampling to pathogen identification.
Notably, the sensitivity of MALDI-TOF MS was significantly higher in the early phase, day − 7 to day +21 of SCT than that in the late phase, day +22 to day +100 (90.0% vs 74.5%, P = 0.037). In particular, the sensitivity in GNR-related BSI in early phase was 100.0 and significantly higher than that in late phase after allo-SCT (60.0%; P = 0.02; Table 2 ). White blood cell counts (WBC) in the early phase were significantly lower than those in the late phase (Table 2 ). In contrast, sensitivity of MALDI-TOF MS in BSI patients with WBC above 1 × 10 9 /L was 71.0% and significantly lower than that in BSI with WBC less than 1 × 10 9 /L (P = 0.005; Table 2 ).
We have demonstrated rapid and reliable identification of causative bacteria by MALDI-TOF MS in BSI patients during allo-SCT. The sensitivity of MALDI-TOF MS in BSI was higher in patients with low WBC counts, and it was useful in neutropenic periods after SCT. Mortality of pre-engraftment BSI is much higher than that of post-engraftment BSI, 5, 6 emphasizing the importance of rapid identification of the pathogens in pre-engraftment BSI. Although the mechanism by which high WBC count was associated with low sensitivity of MALDI-TOF MS remains to be clarified, it is possible that protein derived from WBCs could interfere with bacterial spectral peak in the patients with high WBC counts.
We found that sensitivity of MALDI-TOF MS was highest in neutropenic BSI caused by GNRs after allo-SCT. Although the incidence of BSI in the neutropenic period of allo-SCT has decreased with the widespread use of fluoroquinolone prophylaxis, 12 BSI caused by fluoroquinolone-resistance GNR has become a potential life-threatening complication of SCT. 13 Therefore, the excellent sensitivity of MALDI-TOF MS to GNRs in the early phase during allo-SCT may have a great advantage for treatment of BSI in this phase of allo-SCT. In addition, MALDI-TOF MS performs well with the identification and rapid diagnosis of nonfermenting Gram-negative bacilli, 14 such as Stenotrophomonas maltophilia showing multi-drug resistance and leading to a failure of empirical antibiotic therapy. Because immediate removal of the central venous catheter is recommended in BSI caused by Stenotrophomonas maltophilia in neutropenic period, 15 rapid and accurate detection of this pathogen using MALDI-TOF MS may encourage timely catheter removal and improve patient outcomes.
The major weakness of MALDI-TOF MS in comparison with conventional technique is the lack of the information on antibiotic susceptibility of bacteria. Therefore, choice of antibiotics should be based on the results of MALDI-TOF MS and the institutional antibiogram. Moreover, it is important to confirm antibiotic sensitivity based on the results of conventional biochemical methods.
In conclusion, MALDI-TOF MS allows rapid and reliable identification of pathogens of BSI during allo-SCT, showing the highest sensitivity in neutropenic patients with GNR and Letter to the Editor
